Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome

Diabetes Care

Volumn 36, Issue 4, 2013, Pages 817-822

  Visser, Nora A ^a   Vrancken, Alexander F J E ^a   Van Der Schouw, Yvonne T ^b   Van Den Berg, Leonard H ^a   Notermans, Nicolette C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC IDIOPATHIC AXONAL POLYNEUROPATHY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; PREVALENCE; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; POLYNEUROPATHIES; RISK FACTORS;

EID: 84875414628     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0469     Document Type: Article

References (39)

1. Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001;8:157-165
2. Rudolph T, Farbu E. Hospital-referred polyneuropathiesdcauses, prevalences, clinical-and neurophysiological findings. Eur J Neurol 2007;14:603-608
3. Jann S, Beretta S, BramerioM, Defanti CA. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001;24:1197-1201
4. Notermans NC, Wokke JH, Franssen H, et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066-1071
5. Rosenberg NR, Vermeulen M. Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J Neurol Neurosurg Psychiatry 2005;76:1415-1419
6. Vrancken AF, Franssen H, Wokke JH, Teunissen LL, Notermans NC. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people. Arch Neurol 2002;59:533-540
7. Dyck PJ, Dyck PJ, Klein CJ, Weigand SD. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve 2007;36:536-541
8. Dyck PJ, Clark VM, Overland CJ, et al. Impaired glycemia and diabetic polyneuropathy: the OC IG Survey. Diabetes Care 2012;35:584-591
9. Rajabally YA. Neuropathy and impaired glucose tolerance: an updated review of the evidence. ActaNeurol Scand 2011;124:1-8
10. Teunissen LL, Notermans NC, Jansen GH, Banga JD, Veldman H, Wokke JH. Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy. Acta Neuropathol 2000; 100:445-450
11. Grundy SM, Cleeman JI, Daniels SR, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752
12. Merkies IS, Lauria G. 131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands. Neuromuscul Disord 2006;16:149-156
13. Erdmann PG, Teunissen LL, van Genderen FR, et al. Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). J Neurol 2007;254:1204-1211
14. Merkies IS, Schmitz PI, van der Meché FG, van Doorn PA; The Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2000;68:669-671
15. Rajabally YA, Narasimhan M. Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2010;297:11-14
16. Franssen H, Notermans NC, Wieneke GH. The influence of temperature on nerve conduction in patients with chronic axonal polyneuropathy. Clin Neurophysiol 1999;110:933-940
17. England JD, Gronseth GS, Franklin G, et al; American Academy ofNeurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64:199-207
18. Vrancken AF, Kalmijn S, Brugman F, Rinkel GJ, Notermans NC. The meaning of distal sensory loss and absent ankle reflexes in relation to age: a meta-analysis. J Neurol 2006;253:578-589
19. Vrancken AF, Notermans NC, Wokke JH, Franssen H. The realistic yield of lower leg SNAP amplitudes and SRAR in the routine evaluation of chronic axonal polyneuropathies. J Neurol 2008;255:1127-1135
20. Rajabally YA, Nicolas G, Piéret F, Bouche P, Van den Bergh PY. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009;80:1364-1368
21. Lebrun CE, van der Schouw YT, Bak AA, et al. Arterial stiffness in postmenopausal women: determinants of pulse wave velocity. J Hypertens 2002;20:2165-2172
22. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT. Endogenous sex hormones and metabolic syndrome in agingmen. J Clin Endocrinol Metab 2005;90:2618-2623
23. van den Donk M, Bobbink IW, Gorter KJ, Salomé PL, Rutten GE. Identifying people with metabolic syndrome in primary care by screening with a mailed tape measure: a survey of 14, 000 people in the Netherlands. Prev Med 2009;48:345-350
24. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112:666-673
25. Blokstra A, Vissink P, Venmans LMAJ, et al. Measuring the Netherlands. A monitoring study of risk factors in the general population, 2009-2010. The National Institute for Public Health and the Environment (RIVM) report 260152001/ 2011:1-27. Available at: www.rivm.nl/en. Accessed July 9, 2012
26. Teunissen LL, Franssen H, Wokke JH, et al. Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? J Neurol Neurosurg Psychiatry 2002;72:590-595
27. Zarrelli MM, Amoruso L, Beghi E, Apollo F, Di Viesti P, Simone P; Italian General Practitioner Study Group. Arterial hypertension as a risk factor for chronic symmetric polyneuropathy. J Epidemiol Biostat 2001;6:409-413
28. Cho DY, Mold JW, Roberts M. Further investigation of the negative association between hypertension and peripheral neuropathy in the elderly: an Oklahoma Physicians Resource/Research Network (OKPRN) Study. J Am Board Fam Med 2006;19:240-250
29. Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: ameta-analysis. J Clin Epidemiol 2008;61:646-653
30. Hughes RA, Umapathi T, Gray IA, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004;127:1723-1730
31. Rajabally YA, Shah RS. Dyslipidaemia in chronic acquired distal axonal polyneuropathy. J Neurol 2011;258:1431-1436
32. Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 2006;63:1075-1079
33. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001;24:1229-1231
34. Smith AG, Rose K, Singleton Jr. Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci 2008;273:25-28
35. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003;60:108-111
36. Balion CM, Raina PS, Gerstein HC, et al. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Clin Chem Lab Med 2007;45:1180-1185
37. Callaghan BC, ChengHT, StablesCL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012;11:521-534
38. Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 2010;12:448-455
39. Jonk AM, Houben AJ, de Jongh RT, Serné EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda) 2007;22:252-260